Oral Proteolytic Enzymes: What the Research Shows About Pain, Inflammation, and Healing
Proteolytic enzymes are substances that break down proteins. In the human body, they are involved in digestion, immune regulation, inflammation control, and tissue repair. For decades, researchers have investigated whether supplemental proteolytic enzymes—derived primarily from plants such as pineapple (bromelain) and papaya (papain)—can influence inflammation, pain, and recovery following injury or surgery.
Early clinical research focused on postoperative swelling and pain. Later studies expanded into musculoskeletal disorders, rheumatic conditions, and comparisons with conventional anti-inflammatory medications.
Early Research: Surgery, Pain, and Inflammation
Some of the earliest clinical studies on oral enzyme therapy appeared in dental and obstetric journals in the 1960s.
A study published in the Journal of Dental Disease (1964;19(2):73–77) evaluated bromelain supplementation before and after dental surgery. Patients receiving bromelain experienced a marked reduction in postoperative inflammation, a shorter duration of swelling, and less pain compared to controls.
Similar findings were reported in the Journal of the American Dental Association (1966;72:1420–1425). In that study, patients undergoing dental surgery were given a proteolytic enzyme derived from Carica papaya or a placebo. Those receiving the enzyme had reduced inflammation, less pain, and faster wound healing.
Enzyme therapy was also studied following episiotomy. Research published in Obstetrics and Gynecology (1967;29(2):275–278) found that women receiving bromelain after delivery required fewer pain medications and had fewer infections compared to placebo. Another study in Current Therapeutic Research (1962;4(5):229–237) reported reduced swelling and inflammation using a papaya-derived enzyme following episiotomy.
Across these early trials, enzyme therapy was generally well tolerated and associated with fewer postoperative complications.
Expansion of Research: Musculoskeletal and Rheumatic Conditions
Beginning in the 1980s and 1990s, researchers began exploring oral proteolytic enzymes in musculoskeletal and inflammatory conditions.
Studies published in Wiener Medizinische Wochenschrift examined enzyme combinations in cervical spine syndromes, activated arthrosis, and rheumatic pain. Several of these trials were double-blind and compared enzyme therapy directly with non-steroidal anti-inflammatory drugs (NSAIDs). Results showed reductions in pain and inflammation with enzyme therapy and generally favorable tolerance.
A randomized comparative study published in Clinical and Experimental Rheumatology (2006;24(1):25–30) evaluated an oral enzyme combination in patients with painful osteoarthritis of the hip, comparing it to NSAID therapy. The authors reported comparable improvements in pain with good tolerability.
Other studies explored enzyme use in aesthetic surgery, postoperative pain management, and sports recovery, suggesting a potential role in reducing inflammation and supporting tissue repair following physical stress.
Mechanisms of Action and Tissue Repair
More recent research has focused on understanding how proteolytic enzymes may influence inflammation and healing at a biochemical level.
An in vitro study published in Osteoarthritis and Cartilage (2007) examined the effect of MSM and related compounds on cartilage exposed to inflammatory cytokines. The researchers found evidence that these compounds reduced cytokine-mediated damage to cartilage tissue.
A 2018 review in Advances in Therapy (2018;35(1):31–42) discussed the role of trypsin and chymotrypsin in tissue repair, outlining how proteolytic enzymes may help modulate inflammation, edema, and immune signaling involved in healing processes.
Additional research has examined enzyme therapy in immune modulation, postoperative recovery, and chronic inflammatory conditions, reflecting continued scientific interest over multiple decades.
A Broader Perspective
Taken together, this body of research suggests that oral proteolytic enzymes have been repeatedly studied as adjuncts in conditions involving inflammation, pain, and tissue repair. While study designs, populations, and outcomes vary, the consistency of investigation—from early surgical studies to later randomized trials in musculoskeletal disease—indicates that enzyme therapy is not a fringe concept, but an area of ongoing clinical interest.
As with many aspects of natural health care, enzyme therapy is best viewed within a broader framework that considers hydration, nutrition, movement, and overall inflammatory burden, rather than as a stand-alone solution.
Other References:
- Antibiot Khimioter. 2012;57(9-10):25-7, 29-31 [Impact of exogenous proteolytic enzymes on immunogenesis in patients with urogenital infections]
- Br J Obstet Gynaecol. 1983 Jul;90(7):650-3 Polyglycolic acid and catgut sutures, with and without oral proteolytic enzymes, in the healing of episiotomies
- Aesthetic Plast Surg. Jan-Feb 1999;23(1):41-4. Orally administered proteases in aesthetic surgery
- 1993 Dec;42(12):856-61 [Perioperative enzyme therapy. A significant supplement to postoperative pain therapy?]
- Wien Med Wochenschr. 1996;146(5):91-5 [Results of a double-blind, randomized comparative study of Wobenzym-placebo in patients with cervical syndrome]
- Wien Med Wochenschr. 1996;146(3):55-8. [Drug therapy of activated arthrosis. On the effectiveness of an enzyme mixture versus diclofenac]
- Wien Med Wochenschr. 1999;149(21-22):577-80. [Reducing pain by oral enzyme therapy in rheumatic diseases]
- Adv Ther 2018 Jan;35(1):31-42. The Role of Trypsin:Chymotrypsin in Tissue Repair
- Journal of Strength and Conditioning Research (2007 Aug;21(3):661-7)
- Clinical Experimental Rheumatology (2006 Jan-Feb;24(1):25-30) Efficacy and tolerance of an oral enzyme combination in painful osteoarthritis of the hip. A double-blind, randomised study comparing oral enzymes with non-steroidal anti-inflammatory drugs
